PortfoliosLab logoPortfoliosLab logo
ISIN
US0396971071
CUSIP
039697107
IPO Date
Jun 19, 2014

Highlights

Market Cap
$1.22B
Enterprise Value
$1.40B
EPS (TTM)
-$0.24
Total Revenue (TTM)
$427.68M
Gross Profit (TTM)
$395.63M
EBITDA (TTM)
-$28.55M
Year Range
$4.24 - $8.40
Target Price
$17.00
ROA (TTM)
-11.51%
ROE (TTM)
-39.07%
Avg. Volume (1M)
3M
Avg. Volume Value (1M)
$13.98M

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

ARDX Performance Chart

Ardelyx, Inc. (ARDX) is down 15.1% since the beginning of the year. At $5 per share, ARDX is trading 41.1% below its 52-week high of $8. Investors who bought $1,000 worth of ARDX shares 5 years ago would now be looking at an investment worth $2,845.


Loading charts...

Benchmark

Compare this symbol against anything

Returns By Period

Ardelyx, Inc. (ARDX) has returned -15.09% so far this year and 14.32% over the past 12 months. Over the last ten years, ARDX has returned -7.19% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.


Ardelyx, Inc.

1D
-1.79%
1M
-6.07%
6M
-35.63%
YTD
-15.09%
1Y
14.32%
3Y*
8.83%
5Y*
23.26%
10Y*
-7.19%
ALL TIME*
-8.49%

Benchmark (S&P 500 Index)

1D
0.70%
1M
0.09%
6M
7.94%
YTD
9.41%
1Y
20.07%
3Y*
17.84%
5Y*
11.25%
10Y*
13.26%
ALL TIME*
8.09%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ARDX Monthly Returns History

Based on dividend-adjusted daily data since Jun 19, 2014, ARDX's average daily return is +0.11%, while the average monthly return is +1.89%. At this rate, an investment would double in approximately 3.1 years.

Historically, 48% of months were positive and 52% were negative. The best month was Mar 2023 with a return of +66.3%, while the worst month was Jul 2021 at -77.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ARDX closed higher 47% of trading days. The best single day was Sep 3, 2019 with a return of +71.2%, while the worst single day was Jul 20, 2021 at -73.9%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202631.90%-14.82%-8.55%5.68%-4.58%-15.56%-2.94%-15.09%
20255.72%0.00%-8.40%12.12%-33.33%6.81%8.16%50.00%-13.36%9.98%-4.29%0.52%14.99%
202440.81%6.76%-21.67%-12.33%7.19%8.02%-25.10%11.35%11.49%-14.80%-3.41%-10.58%-18.23%
20232.81%-1.71%66.32%-6.89%-25.11%1.50%16.22%8.12%-4.23%-3.19%14.18%37.47%117.54%
2022-24.89%-6.80%38.96%-23.09%-20.25%-10.12%18.33%35.80%25.54%26.05%14.67%65.70%159.09%
20214.95%-5.01%2.64%10.42%-2.19%6.01%-77.04%-18.97%-6.38%-8.33%-5.79%-3.51%-83.00%

Benchmark Metrics

Ardelyx, Inc. has an annualized alpha of 14.83%, beta of 1.15, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since June 19, 2014.

  • This stock participated in 141.24% of S&P 500 Index downside but only 50.99% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
14.83%
Beta
1.15
0.06
Upside Capture
50.99%
Downside Capture
141.24%

Return for Risk

Risk / Return Rank

ARDX ranks 56 for risk / return — above 56% of stocks peers on PortfoliosLab. Its historical combined result is near the middle of the peer group.


ARDX Risk / Return Rank: 5656
Overall Rank
ARDX Sharpe Ratio Rank: 5555
Sharpe Ratio Rank
ARDX Sortino Ratio Rank: 5757
Sortino Ratio Rank
ARDX Omega Ratio Rank: 5656
Omega Ratio Rank
ARDX Calmar Ratio Rank: 5656
Calmar Ratio Rank
ARDX Martin Ratio Rank: 5555
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

Risk / Return Metrics

The table below present risk-adjusted performance metrics for Ardelyx, Inc. (ARDX) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ARDXBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-1.14

Sortino ratioReturn per unit of downside risk

-1.02

Omega ratioGain probability vs. loss probability

1.11

1.25

-0.14

Calmar ratioReturn relative to maximum drawdown

0.44

2.00

-1.56

Martin ratioReturn relative to average drawdown

0.82

8.49

-7.68

Dividends

Dividend History


Ardelyx, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Ardelyx, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ardelyx, Inc. was 98.45%, occurring on Jun 14, 2022. The portfolio has not yet recovered.

The current Ardelyx, Inc. drawdown is 84.95%.


Drawdown

Fall

Recovery

Underwater

Related event

-98.45%Jun 2022
7y 6mo
11y 8moDec 2014 - now
Bear market2022
-43.00%Aug 2014
1mo 9d1mo 19d
2mo 28dJul 2014 - Oct 2014
-21.22%Oct 2014
2d1mo 18d
1mo 20dOct 2014 - Nov 2014
-2.69%Jun 2014
1d4d
4dJun 2014 - Jun 2014
-2.28%Jun 2014
1d2d
2dJun 2014 - Jun 2014

Drawdown Indicators


ARDXBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-98.45%

-56.78%

-41.67%

Max Drawdown (1Y)

Largest decline over 1 year

-38.05%

-9.10%

-28.95%

Max Drawdown (3Y)

Largest decline over 3 years

-66.32%

-18.90%

-47.42%

Max Drawdown (5Y)

Largest decline over 5 years

-69.99%

-25.43%

-44.56%

Max Drawdown (10Y)

Largest decline over 10 years

-96.82%

-33.92%

-62.90%

Current Drawdown

Current decline from peak

-84.95%

-1.58%

-83.37%

Average Drawdown

Average peak-to-trough decline

-77.43%

-10.70%

-66.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.58%

2.14%

+18.44%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Ardelyx, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Ardelyx, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ARDX relative to other companies in the Biotechnology industry. Currently, ARDX has a P/S ratio of 2.8. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ARDX in comparison with other companies in the Biotechnology industry. Currently, ARDX has a P/B value of 8.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ARDX

Add Ardelyx, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ARDX